These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 31281107

  • 1. Blastic Plasmacytoid Dendritic Cell Neoplasm-Current Insights.
    Venugopal S, Zhou S, El Jamal SM, Lane AA, Mascarenhas J.
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):545-554. PubMed ID: 31281107
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
    Pemmaraju N, Madanat YF, Rizzieri D, Fazal S, Rampal R, Mannis G, Wang ES, Foran J, Lane AA.
    Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U.
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A, Sweet K.
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [Abstract] [Full Text] [Related]

  • 7. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
    Lee SS, McCue D, Pemmaraju N.
    Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
    [Abstract] [Full Text] [Related]

  • 8. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ, Paterakis G.
    Curr Oncol Rep; 2020 May 15; 22(6):55. PubMed ID: 32415624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, Gabarin N, Campbell CJV, Duell J, Moshe Y, Mughal T, Mohty M, Angelucci E.
    Clin Lymphoma Myeloma Leuk; 2024 Apr 15; 24(4):e130-e137. PubMed ID: 38267355
    [Abstract] [Full Text] [Related]

  • 11. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K, Denizon N, Besançon A, Farhi J, Lemaire P, Sandrini J, Truong C, Ghnaya H, Baugier de Materre A.
    Biol Blood Marrow Transplant; 2016 Aug 15; 22(8):1357-1367. PubMed ID: 27026248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W, Yu TT, Tang AP, He Young K, Yu L.
    Curr Med Sci; 2021 Jun 15; 41(3):405-419. PubMed ID: 34218354
    [Abstract] [Full Text] [Related]

  • 16. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
    Koerber RM, Held SAE, Vonnahme M, Feldmann G, Wenzel J, Gütgemann I, Brossart P, Heine A.
    J Cancer Res Clin Oncol; 2022 Mar 15; 148(3):743-748. PubMed ID: 34529129
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.